Literature DB >> 19116344

Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid.

Kun Jiang1, Niketa A Patel, James E Watson, Hercules Apostolatos, Eden Kleiman, Olivia Hanson, Masatoshi Hagiwara, Denise R Cooper.   

Abstract

Serine/arginine-rich (SR) proteins play essential roles in the constitutive and regulated splicing of precursor mRNAs. Phosphorylation of the arginine/serine dipeptide-rich (RS) domain by SR protein kinases such as Cdc2-like kinases (Clk/Sty) modulates their subcellular localization and activation. However, it remains unclear how these kinases and their target SR proteins are regulated by extracellular signals. Regulation of protein kinase C betaII (PKCbetaII) pre-mRNA alternative splicing via exon inclusion by Akt2, a central kinase in insulin action, involves phosphorylation of SR proteins. Here we showed that Akt2, in response to insulin, resulted in phosphorylation of Clk/Sty, which then altered SR protein phosphorylation in concert with Akt2. Insulin-stimulated PKCbetaII pre-mRNA splicing was blocked by Clk/Sty and phosphatidylinositol-3-kinase inhibitors, and diabetic Akt2-null mouse tissues had impaired phospho-Clk/Sty, SR protein phosphorylation, and PKCbetaII expression. Furthermore, we observed that Akt2 phosphorylated several SR proteins distinct from Clk/Sty in response to insulin. Akt2-catalyzed phosphorylation of Clk/Sty and SR proteins revealed a role for both kinases in splicing regulation indicating dual functions for Akt2 in response to insulin in this pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116344      PMCID: PMC2671910          DOI: 10.1210/en.2008-0818

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  41 in total

1.  STY, a tyrosine-phosphorylating enzyme with sequence homology to serine/threonine kinases.

Authors:  B W Howell; D E Afar; J Lew; E M Douville; P L Icely; D A Gray; J C Bell
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

2.  Activity and autophosphorylation of LAMMER protein kinases.

Authors:  K Lee; C Du; M Horn; L Rabinow
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

3.  Characterization and comparison of four serine- and arginine-rich (SR) protein kinases.

Authors:  O Nayler; S Stamm; A Ullrich
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

4.  A carboxy-terminal deletion mutant of protein kinase C beta II inhibits insulin-stimulated 2-deoxyglucose uptake in L6 rat skeletal muscle cells.

Authors:  C E Chalfant; S Ohno; Y Konno; A A Fisher; L D Bisnauth; J E Watson; D R Cooper
Journal:  Mol Endocrinol       Date:  1996-10

5.  Protein kinase C beta II specifically binds to and is activated by F-actin.

Authors:  G C Blobe; D S Stribling; D Fabbro; S Stabel; Y A Hannun
Journal:  J Biol Chem       Date:  1996-06-28       Impact factor: 5.157

6.  Characterization by cDNA cloning of two new human protein kinases. Evidence by sequence comparison of a new family of mammalian protein kinases.

Authors:  J Hanes; H von der Kammer; J Klaudiny; K H Scheit
Journal:  J Mol Biol       Date:  1994-12-16       Impact factor: 5.469

7.  3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase.

Authors:  D R Alessi; M Deak; A Casamayor; F B Caudwell; N Morrice; D G Norman; P Gaffney; C B Reese; C N MacDougall; D Harbison; A Ashworth; M Bownes
Journal:  Curr Biol       Date:  1997-10-01       Impact factor: 10.834

8.  Regulation of alternative splicing of protein kinase C beta by insulin.

Authors:  C E Chalfant; H Mischak; J E Watson; B C Winkler; J Goodnight; R V Farese; D R Cooper
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

9.  The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.

Authors:  K Colwill; T Pawson; B Andrews; J Prasad; J L Manley; J C Bell; P I Duncan
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

10.  A monoclonal antibody that recognizes a phosphorylated epitope stains lampbrush chromosome loops and small granules in the amphibian germinal vesicle.

Authors:  M B Roth; C Murphy; J G Gall
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

View more
  54 in total

1.  The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus.

Authors:  Zhihong Zhou; Jinsong Qiu; Wen Liu; Yu Zhou; Ryan M Plocinik; Hairi Li; Qidong Hu; Gourisanker Ghosh; Joseph A Adams; Michael G Rosenfeld; Xiang-Dong Fu
Journal:  Mol Cell       Date:  2012-06-21       Impact factor: 17.970

2.  Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.

Authors:  Y Tang; I Horikawa; M Ajiro; A I Robles; K Fujita; A M Mondal; J K Stauffer; Z-M Zheng; C C Harris
Journal:  Oncogene       Date:  2012-07-09       Impact factor: 9.867

3.  Insulin promotes neuronal survival via the alternatively spliced protein kinase CδII isoform.

Authors:  André Apostolatos; Shijie Song; Sandra Acosta; Mishka Peart; James E Watson; Paula Bickford; Denise R Cooper; Niketa A Patel
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

4.  Antagonistic roles of four SR proteins in the biosynthesis of alternatively spliced tissue factor transcripts in monocytic cells.

Authors:  Sajiv Chandradas; Gintaras Deikus; Jonathan G Tardos; Vladimir Y Bogdanov
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

5.  Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis.

Authors:  Jussi Pihlajamäki; Carles Lerin; Paula Itkonen; Tanner Boes; Thomas Floss; Joshua Schroeder; Farrell Dearie; Sarah Crunkhorn; Furkan Burak; Josep C Jimenez-Chillaron; Tiina Kuulasmaa; Pekka Miettinen; Peter J Park; Imad Nasser; Zhenwen Zhao; Zhaiyi Zhang; Yan Xu; Wolfgang Wurst; Hongmei Ren; Andrew J Morris; Stefan Stamm; Allison B Goldfine; Markku Laakso; Mary Elizabeth Patti
Journal:  Cell Metab       Date:  2011-08-03       Impact factor: 27.287

Review 6.  The role of RNA alternative splicing in regulating cancer metabolism.

Authors:  Itamar Kozlovski; Zahava Siegfried; Adi Amar-Schwartz; Rotem Karni
Journal:  Hum Genet       Date:  2017-04-20       Impact factor: 4.132

7.  A Cell-Autonomous Signature of Dysregulated Protein Phosphorylation Underlies Muscle Insulin Resistance in Type 2 Diabetes.

Authors:  Thiago M Batista; Ashok Kumar Jayavelu; Nicolai J Wewer Albrechtsen; Salvatore Iovino; Jasmin Lebastchi; Hui Pan; Jonathan M Dreyfuss; Anna Krook; Juleen R Zierath; Matthias Mann; C Ronald Kahn
Journal:  Cell Metab       Date:  2020-09-03       Impact factor: 27.287

Review 8.  Regulation of splicing by SR proteins and SR protein-specific kinases.

Authors:  Zhihong Zhou; Xiang-Dong Fu
Journal:  Chromosoma       Date:  2013-03-24       Impact factor: 4.316

9.  Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk).

Authors:  Bryan T Mott; Cordelle Tanega; Min Shen; David J Maloney; Paul Shinn; William Leister; Juan J Marugan; James Inglese; Christopher P Austin; Tom Misteli; Douglas S Auld; Craig J Thomas
Journal:  Bioorg Med Chem Lett       Date:  2009-10-03       Impact factor: 2.823

10.  Adipose tissue INSR splicing in humans associates with fasting insulin level and is regulated by weight loss.

Authors:  Dorota Kaminska; Maija Hämäläinen; Henna Cederberg; Pirjo Käkelä; Sari Venesmaa; Pekka Miettinen; Imre Ilves; Karl-Heinz Herzig; Marjukka Kolehmainen; Leila Karhunen; Johanna Kuusisto; Helena Gylling; Markku Laakso; Jussi Pihlajamäki
Journal:  Diabetologia       Date:  2013-11-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.